All In Biotech

Drug Trial Radar · NCT05106387

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 With Vonsetamig (BCMA x CD3 Bispecific Antibody) Who Receive a Kidney Transplant

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Oct 19, 2023

Primary completion

Jun 14, 2027

Study completion Feb 23, 2028

Sponsor

Lead sponsor
Regeneron PharmaceuticalsRegeneron (REGN)
Sponsor type
Industry
First posted
Nov 3, 2021

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.

Conditions

  • Chronic Kidney Disease (CKD)

Interventions

  • NoninterventionalDrug

    No investigational treatment will be given in this noninterventional extension study

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Adverse EventsTime frame: Up to 12 months post-kidney transplant
  2. Incidence of Serious Adverse EventsTime frame: Up to 12 months post-kidney transplant

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • University of California Irvine

    Orange, California · Recruiting

  • Connie Frank Transplant Center at UCSF

    San Francisco, California · Recruiting

  • Yale University of Medicine

    New Haven, Connecticut · Completed

  • Comprehensive Transplant Center

    Chicago, Illinois · Recruiting

  • John Hopkins Hospital

    Baltimore, Maryland · Recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Recruiting

  • New York University Langone Health

    New York, New York · Recruiting

  • Penn Transplant Institute

    Philadelphia, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.